Metaplastic Sarcomatoid Carcinoma of the Breast With Absent or Minimal Overt Invasive Carcinomatous Component

ArticleinAmerican Journal of Surgical Pathology 29(11):1456-63 · December 2005with18 Reads
DOI: 10.1097/01.pas.0000176431.96326.49 · Source: PubMed
Metaplastic carcinomas of the breast are a heterogeneous group of neoplasms ranging from tumors with a predominant component of overt carcinoma and focal mesenchymal differentiation to keratin-positive tumors with pure sarcomatoid morphology. We examined the clinicopathologic features of 22 patients previously diagnosed at M.D. Anderson Cancer Center with metaplastic carcinoma of the breast with pure or almost pure sarcomatoid morphology. Patients were included in the study if their tumors had sarcomatoid morphology and: 1) an invasive carcinomatous component identifiable on hematoxylin and eosin stains comprising less than 5% of the invasive tumor; or 2) associated ductal carcinoma in situ; or 3) immunohistochemical expression of keratin in the sarcomatoid areas. Patients with low-grade fibromatosis-like metaplastic tumors and those who received neoadjuvant chemotherapy were excluded. Axillary lymph node dissection or limited axillary node excision was performed in 17 patients, including 1 patient who had a sentinel lymph node biopsy. Lymph node involvement occurred in only 1 patient and consisted of a single 3.5-mm metastasis. Clinical follow-up was available for 21 patients and ranged from 4 months to 155 months (median follow-up, 35 months). Ten patients experienced local relapse, including 7 of 11 patients treated with breast-conserving surgery, and 9 developed distant metastases, most frequently to the lungs. These findings suggest that metaplastic sarcomatoid carcinomas that lack or have only a minimal overt invasive carcinomatous component have a biologic behavior similar to that of sarcomas. In addition to systemic treatment, early aggressive local therapy is recommended, as these patients have a high rate of local relapse.
  • [Show abstract] [Hide abstract] ABSTRACT: Primary osteosarcoma of the breast is a rare malignant tumour. We report such a case in a 77-year-old lady who presented with a hard lump which was clinically and mammographically indistinguishable from a calcified fibroadenoma. Wide local excision of the lesion was carried out. Detailed histological and immunohistochemical features of the tumour are described. Because there was no evidence of metastasis and adequate local excision, no further treatment was considered necessary and she remains disease free at 39 months.
    Article · Mar 2003
  • [Show abstract] [Hide abstract] ABSTRACT: Introduction Carcinosarcoma is a rare neoplasm in the breast generally associated with an adverse prognosis. Materials and methods we report a case of breast carcinosarcoma in a male breast. Results identification of malignant heterologous elements is the key to use this designation. Conclusions Carcinosarcomas are very aggressive tumours with a worse prognosis compared with ductal adenocarcinomas in the same stage. There are no image and clinical criteria to make an early diagnosis. Histological diagnosis will be definitive.
    Full-text · Article · Jul 2006
  • [Show abstract] [Hide abstract] ABSTRACT: Carcinosarcoma of the breast is rare and accounts for less than 0.1% of all breast malignancies. Carcinosarcomas have traditionally been distinguished from other forms of metaplastic breast carcinoma because they are aggressive and have an ominous prognosis. Metaplastic tumors that show both carcinomatous and sarcomatous features occur in various anatomical sites and, in spite of differences in terminology and exact microscopic composition, evidence suggests these all are similar tumors that develop through a peculiar phenotypic transformation of carcinoma cells into sarcoma. In the breast, the most popular theories regarding the histogenesis of the sarcomatous component of carcinosarcomas and sarcomatoid carcinomas propose the malignant transformation of myoepithelial cells or myofibroblastic metaplasia of malignant epithelial cells. In this chapter, we review the limited published clinical experience with carcinosarcomas of the breast and make therapy recommendations on the basis of available data. In addition, we explore some potentially targetable molecular mechanisms that need to be further explored for their potential to improve the outcomes of patients with these aggressive tumors.
    Chapter · Jul 2006 · Revista Española de Patología
Show more